ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
INVESTORS
[데일리팜] “국산 최초 CAR-T 치료제 개발, 킴리아에 도전장”
2024/08/05
[데일리팜] 국산 최초 CAR-T 치료제 개발, 킴리아에 도전장 (dailypharm.com)
Prev
[헬로디디] 혈액암에 이어 고형암까지···모든 암 정복 꿈꾸는 큐로셀에 관심 집중
Next
큐로셀 ‘안발셀’, 식약처로부터 신속처리 대상 첨단바이오의약품 지정… 심사 기간 단축해 신약 허가 가속화
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.